I believe that you mean hormonal contraception.

Choosing the better and safe method for contraception is usually "Individualised". I mean that each case must be evaluated before deciding if a hormonal contraception will be used or not. Evaluation includes several points even the family history of malignancy, pregnancy test, assessment of the risk of thrombo-embolic diseases, hypertension, osteoporosis, diabetes and hypertension. Many other points to be considered. Even if hormonal contraception will be prescribed, there are many derivatives of progesterone "different generations" that vary in their adverse effect profile. Also, oestrogen with progesterone or progesterone alone is another choice that depends on the specified patient. To summarise, better and safe use vary from one case to another and treatment should be individualised.         

think we should follow the clinical pharmacology evidences.  I dont recommend steroidal OCP for patients with history of breast cancer or thromboembolic disorders. We cannot predict the percentage of appearances of the disease in a particular patient. But medical professionals cannnot get the risk for patients management. 

There are enough other methods for these type of patients. 

We should completely aviod the absolute contraindications and should take precautions and do monitoring of the patient in relative contraindications. 

Thank you Dear Dr Mohamed. I agree with you that  'treatment should be individualised'.

Thank you Dr  Menik, for your impressive and informative comments.